Found: 12
Select item for more details and to access through your institution.
NLRP3 Inhibitor Tranilast Attenuates Gestational Diabetes Mellitus in a Genetic Mouse Model.
- Published in:
- Drugs in R&D, 2022, v. 22, n. 1, p. 105, doi. 10.1007/s40268-022-00382-7
- By:
- Publication type:
- Article
In Vitro Stability and Recovery Studies of Pimavanserin in Water and in Different Vehicles Orally Administered.
- Published in:
- Drugs in R&D, 2022, v. 22, n. 1, p. 95, doi. 10.1007/s40268-022-00381-8
- By:
- Publication type:
- Article
Effect of Severe Renal Impairment on the Safety, Tolerability, and Pharmacokinetics of AMG 986.
- Published in:
- Drugs in R&D, 2022, v. 22, n. 1, p. 89, doi. 10.1007/s40268-021-00380-1
- By:
- Publication type:
- Article
Safety, Pharmacokinetic, and Pharmacodynamic Study of a Sublingual Formula for the Treatment of Vasovagal Syncope.
- Published in:
- Drugs in R&D, 2022, v. 22, n. 1, p. 61, doi. 10.1007/s40268-021-00378-9
- By:
- Publication type:
- Article
Pharmacokinetics of Diazepam and Its Metabolites in Urine of Chinese Participants.
- Published in:
- Drugs in R&D, 2022, v. 22, n. 1, p. 43, doi. 10.1007/s40268-021-00375-y
- By:
- Publication type:
- Article
A Randomized, Double-Blind, Placebo- and Active-Controlled, Escalating Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Subcutaneous Eflapegrastim in Healthy Japanese and Caucasian Subjects.
- Published in:
- Drugs in R&D, 2022, v. 22, n. 1, p. 71, doi. 10.1007/s40268-021-00379-8
- By:
- Publication type:
- Article
Bioequivalence and Safety Assessment of Two Formulations of Metformin Hydrochloride Sustained-Release Tablets (Yuantang<sup>®</sup> SR and Glucophage<sup>®</sup> XR) Under Fed Conditions in Healthy Chinese Adult Subjects: An Open-Label, Two-Way Crossover, Sequence Randomized Phase I Clinical Trial
- Published in:
- Drugs in R&D, 2022, v. 22, n. 1, p. 51, doi. 10.1007/s40268-021-00377-w
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Ibrexafungerp.
- Published in:
- Drugs in R&D, 2022, v. 22, n. 1, p. 9, doi. 10.1007/s40268-021-00376-x
- By:
- Publication type:
- Article
An Evaluation of the Pharmacokinetics, Safety, and Tolerability of Aclidinium/Formoterol Fixed-Dose Combination Administered in Chinese Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease.
- Published in:
- Drugs in R&D, 2022, v. 22, n. 1, p. 35, doi. 10.1007/s40268-021-00374-z
- By:
- Publication type:
- Article
Coenzyme Q10 in the Treatment of Heart Failure with Preserved Ejection Fraction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Drugs in R&D, 2022, v. 22, n. 1, p. 25, doi. 10.1007/s40268-021-00372-1
- By:
- Publication type:
- Article
Pharmacokinetics and Bioequivalence of Sitagliptin Phosphate/Metformin Hydrochloride Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Study.
- Published in:
- Drugs in R&D, 2022, v. 22, n. 1, p. 15, doi. 10.1007/s40268-021-00371-2
- By:
- Publication type:
- Article
The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia.
- Published in:
- Drugs in R&D, 2022, v. 22, n. 1, p. 1, doi. 10.1007/s40268-021-00370-3
- By:
- Publication type:
- Article